Advertisement
Nonfunctioning adrenal tumors or adenomas causing mild autonomous cortisol excess rarely show clinically relevant changes in size or hormone function

Adrenal Incidentalomas Rarely Grow, Change Hormone Function

0
Such tumors may increase risk for comorbid cardiometabolic conditions
Among veterans with posttraumatic stress disorder

Death From Specific Causes Up for Veterans With PTSD

0
Significant increases seen in mortality from suicide, accidental injury, viral hepatitis
During the last 18 years

No Change Seen in Processed Meat Consumption by U.S. Adults

0
During same period, mean consumption decreased for unprocessed red meat, increased for poultry
Maternal obesity and overweight are associated with an increased risk for type 2 diabetes in offspring

T2DM Risk in Offspring Up With Maternal Overweight, Obesity

0
Offspring of women who are overweight or obese during pregnancy have higher risk for type 2 diabetes
The new editor-in-chief of the prestigious New England Journal of Medicine is Eric J. Rubin

New England Journal of Medicine Picks New Editor-in-Chief

0
Eric J. Rubin succeeds Jeffrey Drazen, who has been the editor-in-chief since 2000
Older age

Risk Factors ID’d for Atrial Fibrillation With Type 1 Diabetes

0
Risk factors for developing atrial fibrillation similar to those seen for other forms of cardiovascular disease
Almost all health care workers with acute respiratory illness report working at least one day while symptomatic

Health Care Workers With ARIs Often Work While Symptomatic

0
Likelihood of working higher if symptoms less severe and on illness onset date versus subsequent days
Having diabetes

Late-Life Diabetes Status Tied to New Cognitive Impairment

0
Diabetes in late life with poor glycemic control, longer duration linked to incident cognitive impairment
For patients with diabetes

Outpatient Office Visits Increased With Access to Patient Portal

0
For patients with diabetes and chronic conditions, portal linked to fewer ED visits
Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older

FDA Approves Victoza Injection for Children 10 Years and Older

0
~64 percent of children treated with Victoza achieved HbA1c levels less than 7 percent